Derived neutrophil-to-lymphocyte ratio and platelet to lymphocyte ratio as a prognostic marker for patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.

被引：0
|
作者：
Cai, Guoxin
Yu, Jinming
Meng, Xue
机构：
[1] Shandong Univ, Shandong Canc Hosp, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
[2] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e15575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15575
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neutrophil-to-lymphocyte Ratio: A Surrogate Marker for Prognosis of Oral Squamous Cell Carcinoma
    Mahalakshmi, R.
    Boaz, Karen
    Srikant, N.
    Baliga, Mohan
    Shetty, Premalatha
    Prasad, Mukul
    Yellapurkar, Shweta
    Lewis, Amitha J.
    [J]. INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (01) : 8 - 12
  • [22] The Predictive Value of Pretreatment Neutrophil-To-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma
    Miao-Fen Chen
    Ping-Tsung Chen
    Feng-Che Kuan
    Wen-Cheng Chen
    [J]. Annals of Surgical Oncology, 2019, 26 : 190 - 199
  • [23] Neutrophil-to-lymphocyte ratio after neoadjuvant chemotherapy as an independent prognostic factor in patients with esophageal squamous cell carcinoma
    Yamada, Moyuru
    Tanaka, Koji
    Yamasaki, Makoto
    Yamashita, Kotaro
    Makino, Tomoki
    Saito, Takuro
    Takahashi, Tsuyoshi
    Kurokawa, Yukinori
    Motoori, Masaaki
    Kimura, Yutaka
    Nakajima, Kiyokazu
    Eguchi, Hidetoshi
    Doki, Yuichiro
    [J]. ONCOLOGY LETTERS, 2023, 25 (02)
  • [24] Prognostic value of neutrophil-to-lymphocyte ratio in peripheral blood and pathological tissue in patients with esophageal squamous cell carcinoma
    Guo, Quanquan
    Shao, Zhiying
    Xu, Dan
    Fan, Lili
    Xiong, Huiru
    Ding, Xin
    You, Chuanwen
    Zhang, Longzhen
    [J]. MEDICINE, 2020, 99 (29): : E21306
  • [25] Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Anand, Santhosh
    Bhati, Gajendra
    Gurram, Ramprakash
    Gnanasekaran, Senthil
    Kate, Vikram
    Pottakkat, Biju
    Kalayarasan, Raja
    [J]. JOURNAL OF GASTROINTESTINAL CANCER, 2021, 52 (02) : 659 - 665
  • [26] Does Neutrophil-to-Lymphocyte Ratio (NLR) Predict Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma?
    Santhosh Anand
    Gajendra Bhati
    Ramprakash Gurram
    Senthil Gnanasekaran
    Vikram Kate
    Biju Pottakkat
    Raja Kalayarasan
    [J]. Journal of Gastrointestinal Cancer, 2021, 52 : 659 - 665
  • [27] Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)
    Trinh, Hamilton
    Dzul, Stephen Paul
    Hyder, Jalal
    Jang, Hyejeong
    Kim, Seongho
    Flowers, Julianne
    Vaishampayan, Nitin
    Chen, Jerry
    Winer, Ira
    Miller, Steven
    [J]. CLINICA CHIMICA ACTA, 2020, 510 : 711 - 716
  • [28] Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT)
    Hyder, J.
    Jang, H.
    Kim, S.
    Trinh, H.
    Chen, J.
    Flowers, J.
    Vaishampayan, N. G.
    Winer, I.
    Miller, S. R., II
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E663 - E664
  • [29] Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases
    Quirina C. B. S. Thio
    W. Alexander Goudriaan
    Stein J. Janssen
    Nuno Rui Paulino Pereira
    Daniel M. Sciubba
    Rachel P. Rosovksy
    Joseph H. Schwab
    [J]. British Journal of Cancer, 2018, 119 : 737 - 743
  • [30] Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with recurrent oral squamous cell carcinoma treated with nivolumab
    Tachinami, Hidetake
    Tomihara, Kei
    Yamada, Shin-ichi
    Ikeda, Atsushi
    Imaue, Shuichi
    Hirai, Hideaki
    Nakai, Hiromi
    Sonoda, Tomoko
    Kurohara, Kazuto
    Yoshioka, Yukio
    Hasegawa, Takumi
    Naruse, Tomofumi
    Niiyama, Takashi
    Shimane, Tetsu
    Ueda, Michihiro
    Yanamoto, Souichi
    Akashi, Masaya
    Umeda, Masahiro
    Kurita, Hiroshi
    Miyazaki, Akihiro
    Arai, Naoya
    Hayashi, Ryuji
    Noguchi, Makoto
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2023, 61 (04): : 320 - 326
12345